Wang J - Search Results

1

Pediatric Renal Ontogeny and Applications in Drug Development.

Zhang Y, Mehta N, Muhari-Stark E, Burckart GJ, van den Anker J, Wang J. Zhang Y, et al. Among authors: wang j. J Clin Pharmacol. 2019 Sep;59 Suppl 1:S9-S20. doi: 10.1002/jcph.1490. J Clin Pharmacol. 2019. PMID: 31502684 Review.

2

The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice.

Wang J, Figurski M, Shaw LM, Burckart GJ. Wang J, et al. Transpl Immunol. 2008 Jul;19(3-4):192-6. doi: 10.1016/j.trim.2008.05.009. Epub 2008 Jun 18. Transpl Immunol. 2008. PMID: 18586494

3

Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.

Wang J, Edginton AN, Avant D, Burckart GJ. Wang J, et al. J Clin Pharmacol. 2015 Oct;55(10):1175-83. doi: 10.1002/jcph.524. Epub 2015 Jun 9. J Clin Pharmacol. 2015. PMID: 25907280

4

A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.

Wang J, Avant D, Green D, Seo S, Fisher J, Mulberg AE, McCune SK, Burckart GJ. Wang J, et al. Clin Pharmacol Ther. 2015 Sep;98(3):328-35. doi: 10.1002/cpt.149. Clin Pharmacol Ther. 2015. PMID: 25975723 Review.

5

Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants.

Duan P, Fisher JW, Yoshida K, Zhang L, Burckart GJ, Wang J. Duan P, et al. Among authors: wang j. Clin Pharmacokinet. 2017 Apr;56(4):383-394. doi: 10.1007/s40262-016-0445-9. Clin Pharmacokinet. 2017. PMID: 27596256

6

Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug Development.

McMahon AW, Watt K, Wang J, Green D, Tiwari R, Burckart GJ. McMahon AW, et al. Among authors: wang j. Ther Innov Regul Sci. 2016;2016:1-6. doi: 10.1177/2168479016651661. Epub 2016 Jun 2. Ther Innov Regul Sci. 2016. PMID: 27774353 Free PMC article.

7

Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.

Wang J, Johnson T, Sahin L, Tassinari MS, Anderson PO, Baker TE, Bucci-Rechtweg C, Burckart GJ, Chambers CD, Hale TW, Johnson-Lyles D, Nelson RM, Nguyen C, Pica-Branco D, Ren Z, Sachs H, Sauberan J, Zajicek A, Ito S, Yao LP. Wang J, et al. Clin Pharmacol Ther. 2017 Jun;101(6):736-744. doi: 10.1002/cpt.676. Clin Pharmacol Ther. 2017. PMID: 28510297 Free PMC article. Review.

8

Neonatal Safety Information Reported to the FDA During Drug Development Studies.

Avant D, Baer G, Moore J, Zheng P, Sorbello A, Ariagno R, Yao L, Burckart GJ, Wang J. Avant D, et al. Among authors: wang j. Ther Innov Regul Sci. 2017;2017:1-9. doi: 10.1177/2168479017716713. Epub 2017 Jun 28. Ther Innov Regul Sci. 2017. PMID: 28804696 Free PMC article.

9

Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and Immunogenicity.

Wang J, Lon HK, Lee SL, Burckart GJ, Pisetsky DS. Wang J, et al. Ther Innov Regul Sci. 2015 Nov;49(6):861-868. doi: 10.1177/2168479015592195. Ther Innov Regul Sci. 2015. PMID: 30222372

10

Bone Mineral Density to Assess Pediatric Bone Health in Drug Development.

Maas BM, Wang J, Cooner F, Green D, Yuan Y, Yao L, Burckart GJ. Maas BM, et al. Among authors: wang j. Ther Innov Regul Sci. 2017 Nov;51(6):756-760. doi: 10.1177/2168479017709047. Epub 2017 May 11. Ther Innov Regul Sci. 2017. PMID: 30227097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201,904 results

Search Page